In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Biosym Technologies Inc.

Division of Corning Inc.

Latest From Biosym Technologies Inc.

GeneFormatics Inc.

GeneFormatics means to develop computational tools that will help the pharmaceutical industry predict the three-dimensional structures and corresponding functions of proteins.
BioPharmaceutical Research and Development Strategies

Redesigning Drug Design

The torrents of data being generated through combinatorial chemistry and genomics are increasing researchers’ interest in computer-aided drug design. Developers say their new programs are more powerful than ever. The new tools are certainly cheaper,and they are reaching a wider audience of less-expert researchers, in part by building on their familiarity with the Internet and Web.
BioPharmaceutical Business Strategies
See All

Company Information

  • Industry
  • Miscellaneous
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Corning Inc.
  • Senior Management
  • Kevin Roberts, Pres. & CEO
    Todd Schmidt, CFO
    Susan Papanek, Vice Pres., Product Development
    Hollon Bridges, VP, Worldwide Sales & Service
    Arnold T. Hagler, CSO
  • Contact Info
  • Biosym Technologies Inc.
    Phone: (619) 458-9990
    9685 Scranton Road
    San Diego, CA 92121-